Hyloris Pharmaceuticals SA (HYL.BR)
EUR 5.8
(-1.36%)
EUR 5.8
(-1.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.08 Million | 2.95 Million | 3.09 Million | 175 Thousand | 91 Thousand | 91 Thousand |
| Cost of Revenue | 93 Thousand | 94 Thousand | 107 Thousand | 145 Thousand | 66 Thousand | 65 Thousand |
| Gross Profit | 1.99 Million | 2.85 Million | 2.98 Million | 30 Thousand | 25 Thousand | 26 Thousand |
| Operating Expenses | 17.98 Million | 13.36 Million | 13.33 Million | 5.6 Million | 5.29 Million | 5.49 Million |
| Selling, General and Administrative Expenses | 5.54 Million | 3.51 Million | 2.9 Million | 2.19 Million | 808 Thousand | 622 Thousand |
| Research and Development Expenses | 14.42 Million | 10.15 Million | 5.05 Million | 3.41 Million | 4.57 Million | 4.87 Million |
| Other Expenses | -1.98 Million | -303 Thousand | 5.38 Million | -1.46 Million | -86 Thousand | 3000.00 |
| Cost and Expenses | 18.08 Million | 13.45 Million | 13.44 Million | 5.75 Million | 5.36 Million | 5.56 Million |
| Operating Income | -15.99 Million | -10.5 Million | -10.34 Million | -5.57 Million | -5.27 Million | -5.46 Million |
| Interest Expense | 100 Thousand | 219 Thousand | 556 Thousand | 992 Thousand | 411 Thousand | 340 Thousand |
| Income Tax Expense | -446 Thousand | 4000.00 | 297 Thousand | 1000.00 | -14 Thousand | -20 Thousand |
| Earnings before Tax | -15.82 Million | -10.76 Million | -11.28 Million | -7.14 Million | -5.78 Million | -6.05 Million |
| Net Income | -15.38 Million | -10.77 Million | -11.57 Million | -7.14 Million | -5.76 Million | -5.79 Million |
| Earnings Per Share Basic | -0.55 | -0.40 | -0.45 | -0.28 | -1.15 | -0.25 |
| Earnings Per Share Diluted | -0.55 | -0.40 | -0.45 | -0.28 | -1.15 | -0.25 |
| Weighted Average Shares Outstanding | 28 Million | 27.19 Million | 25.83 Million | 25.83 Million | 5 Million | 23.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 28 Million | 27.19 Million | 25.83 Million | 25.83 Million | 5 Million | 23.55 Million |
| Gross Margin | 0.96 | 0.97 | 0.97 | 0.17 | 0.27 | 0.29 |
| EBIT Margin | -7.18 | -3.46 | -3.42 | -32.42 | -22.69 | -61.88 |
| Profit Margin | -7.37 | -3.65 | -3.74 | -40.83 | -63.38 | -63.64 |
| EBITDA | -14.98 Million | -11.43 Million | -10.78 Million | -6.17 Million | -5.26 Million | -5.62 Million |
| Earnings Before Tax Margin | -7.66 | -3.56 | -3.34 | -31.87 | -57.96 | -60.10 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 2.08 Million | 1.52 Million | 1.52 Million | 580 Thousand | 580 Thousand | 2.95 Million |
| Cost of Revenue | 441 Thousand | 23.5 Thousand | 23.5 Thousand | 23 Thousand | 23 Thousand | 94 Thousand |
| Gross Profit | 1.64 Million | 1.5 Million | 1.5 Million | 557 Thousand | 557 Thousand | 2.85 Million |
| Operating Expenses | 19.61 Million | 5.95 Million | 6.05 Million | 4.1 Million | 4.1 Million | 13.36 Million |
| Selling, General and Administrative Expenses | - | 1.52 Million | 1.52 Million | 1.24 Million | 1.24 Million | - |
| Research and Development Expenses | - | 3.77 Million | 3.77 Million | 3.43 Million | 3.43 Million | - |
| Other Expenses | - | 647 Thousand | - | - | - | -303 Thousand |
| Cost and Expenses | 20.06 Million | 5.97 Million | 6.07 Million | 4.13 Million | 4.13 Million | 13.45 Million |
| Operating Income | -17.97 Million | -4.44 Million | -4.41 Million | -3.5 Million | -3.5 Million | -10.5 Million |
| Interest Expense | 52 Thousand | 293 Thousand | - | 100 Thousand | - | 219 Thousand |
| Income Tax Expense | -593 Thousand | -302 Thousand | - | -291 Thousand | - | 4000.00 |
| Earnings before Tax | -15.82 Million | -4.37 Million | -4.37 Million | -3.31 Million | -3.31 Million | -10.76 Million |
| Net Income | -15.38 Million | -4.37 Million | -4.37 Million | -3.31 Million | -3.31 Million | -10.77 Million |
| Earnings Per Share Basic | - | -0.16 | -0.16 | -0.12 | - | - |
| Earnings Per Share Diluted | - | -0.16 | -0.16 | -0.12 | - | - |
| Weighted Average Shares Outstanding | 28 Million | 27.93 Million | 27.93 Million | 28 Million | - | 27.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 28 Million | 28 Million | 28 Million | 28 Million | - | 27.19 Million |
| Gross Margin | 0.79 | 0.98 | 0.98 | 0.96 | 0.96 | 0.97 |
| EBIT Margin | - | -2.87 | -2.86 | -5.91 | -5.91 | - |
| Profit Margin | -7.37 | -2.86 | -2.86 | -5.72 | -5.72 | -3.65 |
| EBITDA | - | -4.38 Million | -4.37 Million | -3.42 Million | -3.42 Million | - |
| Earnings Before Tax Margin | -8.61 | -2.91 | -2.89 | -6.05 | -6.05 | -3.56 |
UNIQ
SANW
CGSI
TGOPF
2668
334890